Business Description
Awakn Life Sciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA05455W1086
Compare
Compare
Traded in other countries / regions
AWKN.CanadaAWKNF.USA954.Germany IPO Date
2021-07-23Description
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -1.74 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -61.05 | |||||
| Beneish M-Score | -30.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -44.9 | |||||
| 3-Year EPS without NRI Growth Rate | -73.6 | |||||
| 3-Year FCF Growth Rate | -26 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.71 | |||||
| 9-Day RSI | 46.58 | |||||
| 14-Day RSI | 48.68 | |||||
| 6-1 Month Momentum % | -27 | |||||
| 12-1 Month Momentum % | -47.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | |||||
| Quick Ratio | 0.35 | |||||
| Cash Ratio | 0.29 | |||||
| Days Sales Outstanding | 376.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -16.9 | |||||
| Shareholder Yield % | -30.38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -3160.24 | |||||
| Net Margin % | -3215.66 | |||||
| FCF Margin % | -483.33 | |||||
| ROA % | -366.02 | |||||
| ROIC % | -2241.88 | |||||
| ROC (Joel Greenblatt) % | -330.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 38.88 | |||||
| EV-to-EBIT | -2 | |||||
| EV-to-EBITDA | -2.02 | |||||
| EV-to-Forward-EBITDA | -0.52 | |||||
| EV-to-Revenue | 64.33 | |||||
| EV-to-Forward-Revenue | 2.2 | |||||
| EV-to-FCF | -9.45 | |||||
| Earnings Yield (Greenblatt) % | -50 | |||||
| FCF Yield % | -7.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AWKNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Awakn Life Sciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.06 | ||
| EPS (TTM) ($) | -0.059 | ||
| Beta | 1.04 | ||
| Volatility % | 98.03 | ||
| 14-Day RSI | 48.68 | ||
| 14-Day ATR ($) | 0.010488 | ||
| 20-Day SMA ($) | 0.08961 | ||
| 12-1 Month Momentum % | -47.17 | ||
| 52-Week Range ($) | 0.04872 - 0.1877 | ||
| Shares Outstanding (Mil) | 41.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Awakn Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Awakn Life Sciences Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Awakn Life Sciences Corp Frequently Asked Questions
What is Awakn Life Sciences Corp(AWKNF)'s stock price today?
The current price of AWKNF is $0.09. The 52 week high of AWKNF is $0.19 and 52 week low is $0.05.
When is next earnings date of Awakn Life Sciences Corp(AWKNF)?
The next earnings date of Awakn Life Sciences Corp(AWKNF) is .
Does Awakn Life Sciences Corp(AWKNF) pay dividends? If so, how much?
Awakn Life Sciences Corp(AWKNF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers